Literature DB >> 18695880

Tumor hypoxia: Impact on gene amplification in glioblastoma.

Ulrike Fischer1, Jens Radermacher, Jens Mayer, Yasmin Mehraein, Eckart Meese.   

Abstract

Gene amplification is frequently found in human glioblastoma but the mechanisms driving amplifications remain to be elucidated. Hypoxia as hallmark of glioblastoma is known to be involved in the induction of fragile sites that are central to gene amplification. We analyzed the potential of hypoxia (pO2 0%) and mini hypoxia (pO2 5%) to induce fragile sites within a homogeneously staining region (HSR) at 12q14-15 in a glioblastoma cell line (TX3868). Treatment of cells by hypoxia or by mini hypoxia induced double minutes (DMs) and caused breakage of the HSR structure at 12q14-15, suggesting a novel hypoxia inducible fragile site on 12q. Treatment with aphidicolin, a known fragile site inducer, indicates that the hypoxia inducible fragile site is a common fragile site. Reintegration of amplified sequences and occurrence of anaphase-bridge-like structures shows that mini hypoxia and hypoxia are able to initiate amplification processes in human glioblastoma cells. Hypoxia as known tumor microenvironment factor is crucial for the development of amplifications in glioblastoma. The identification and characterization of novel common fragile sites induced by hypoxia will improve the understanding of mechanisms underlying amplifications in glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695880

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

Review 1.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy.

Authors:  Jian Qiao; Mahua Dey; Alan L Chang; Julius W Kim; Jason Miska; Alex Ling; Dirk M Nettlebeck; Yu Han; Lingjiao Zhang; Maciej S Lesniak
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

Review 3.  Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.

Authors:  Susan E Scanlon; Peter M Glazer
Journal:  DNA Repair (Amst)       Date:  2015-05-01

Review 4.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

5.  Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma.

Authors:  Vladimir A Valera; Beatriz A Walter; W Marston Linehan; Maria J Merino
Journal:  J Cancer       Date:  2011-10-21       Impact factor: 4.207

6.  Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions.

Authors:  Hanae Ueyama; Tomohisa Horibe; Shiro Hinotsu; Tomoaki Tanaka; Takeomi Inoue; Hisashi Urushihara; Akira Kitagawa; Koji Kawakami
Journal:  J Cell Mol Med       Date:  2012-01       Impact factor: 5.310

7.  Tumor hypoxia as a driving force in genetic instability.

Authors:  Kaisa R Luoto; Ramya Kumareswaran; Robert G Bristow
Journal:  Genome Integr       Date:  2013-10-24

Review 8.  Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.

Authors:  Ivy A W Ho; Winston S N Shim
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

Review 9.  Involvement of Thyroid Hormones in Brain Development and Cancer.

Authors:  Gabriella Schiera; Carlo Maria Di Liegro; Italia Di Liegro
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

Review 10.  Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles.

Authors:  Gabriella Schiera; Carlo Maria Di Liegro; Italia Di Liegro
Journal:  Int J Mol Sci       Date:  2017-12-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.